封面
市場調查報告書
商品編碼
1441272

全球核苷酸市場規模、佔有率、成長分析(按類型、按應用)- 2023-2030 年產業預測

Global Nucleotide Market Size, Share, Growth Analysis, By Type(Food Grade, Lab Grade), By Application(Pharmaceuticals, Food & beverage additive) - Industry Forecast 2023-2030

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計2022年全球核苷酸市場規模為5.9572億美元,從2023年的6.3146億美元成長到2031年的10.00646億美元,在預測期內(2024-2031年)預計年複合成長率為6%。

在全球範圍內,核苷酸的使用在藥品、食品和飲料、飼料和診斷研究等各個領域迅速增加,是市場擴張的驅動力。消費者對某些香料缺點的認知不斷提高,推動了對核苷酸食用香料的需求,從而刺激了成長。特別值得注意的是核苷酸在醫學中的應用不斷升級,特別是在美國和加拿大等地區,這對該行業的擴張產生了積極影響。此外,由於動物健康問題,全球畜牧業需求激增,推動了對核苷酸食品添加劑的需求。此外,核苷酸在診斷研究中的作用不斷擴大,使得檢測疾病和測試各種病毒感染疾病和某些癌症變得更加容易,預計將在短期內進一步推動需求。

目錄

執行摘要

  • 市場概況
  • 命運之輪

調查方法

  • 資訊採購
  • 次要/一級資訊來源
  • 市場規模估算
  • 市場假設與限制

母市場分析

  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務

主要市場考察

  • 技術分析
  • 價格分析
  • 供應鏈分析
  • 價值鏈分析
  • 市場生態系統
  • 智慧財產權分析
  • 貿易分析
  • Start-Ups分析
  • 原料分析
  • 創新矩陣
  • 研發線產品分析
  • 總體經濟指標
  • 主要投資分析
  • 關鍵成功因素
  • 競爭程度

市場動態及展望

  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務
  • 監管形勢
  • 波特的分析
  • 對未來中斷的特殊考慮

全球核苷酸市場:按類型

  • 市場概況
  • 食品級
  • 實驗室級
  • 工業級

全球核苷酸市場:按應用分類

  • 市場概況
  • 藥品
  • 食品/飲料添加劑
  • 動物飼料添加劑
  • 其他

全球核苷酸市場規模:按地區分類

  • 市場概況
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 其他歐洲國家地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲 (MEA)
    • 海灣合作理事會國家
    • 南非
    • 其他中東/非洲地區

競爭形勢

  • 前5名企業對比
  • 主要企業市場定位(2021年)
  • 主要市場參與者所採取的策略
  • 關鍵成功策略
  • 近期市集活動
  • 主要企業市場佔有率(2021年)

主要企業簡介

  • Thermo Fisher Scientific(US)
  • Merck KGaA(Germany)
  • Roche(Switzerland)
  • Agilent Technologies(US)
  • New England BioLabs(US)
  • Takara Bio(Japan)
  • Bio-Rad Laboratories(US)
  • Lonza Group(Switzerland)
  • Promega Corporation(US)
  • QIAGEN(Germany)
  • Creative BioMart(China)
  • Bioss(China)
  • GenScript(China)
  • BioVision(US)
  • Eurofins Scientific(France)
  • Enzo Biochem(US)
  • SERVA Electrophoresis(Germany)
  • IDT(US)
  • Life Technologies(US)
  • Sigma-Aldrich(US)
簡介目錄
Product Code: SQMIG15B2089

Global Nucleotide Market size was valued at USD 595.72 million in 2022 and is poised to grow from USD 631.46 million in 2023 to USD 1006.46 million by 2031, growing at a CAGR of 6% during the forecast period (2024-2031).

Globally, the burgeoning utilization of nucleotides across various sectors such as pharmaceuticals, food and beverage, animal feed, and diagnostic research is set to drive market expansion. Increased consumer awareness regarding the drawbacks of certain flavoring agents is propelling the demand for nucleotide-based flavor enhancers, thereby stimulating growth. Particularly notable is the escalating application of nucleotides in pharmaceuticals, notably in regions like the U.S. and Canada, which is positively impacting industry expansion. Moreover, the global surge in demand within the livestock sector due to animal health concerns is driving the need for nucleotide-based food additives. Additionally, the expanding role of nucleotides in diagnostic research, facilitating disease detection and testing for various viral infections or specific cancers, is expected to further fuel demand in the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nucleotide Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nucleotide Market Segmental Analysis

The global nucleotide market is segmented on the basis of type, application, region. By type, the market is segmented into food grade, lab grade, industry grade. By application, the market is segmented into pharmaceuticals, food & beverage additive, animal feed additive, diagnostics research. By region, the market is segmented into North America, Europe, Latin America, Asia- Pacific, Middle East and Africa.

Drivers of the Global Nucleotide Market

The ongoing progress in pharmaceutical research and development drives the global nucleotide market forward, as nucleotides prove indispensable in various facets such as drug discovery, gene therapies, and personalized medicine. This essential role within the pharmaceutical industry fuels the increasing demand for nucleotides worldwide.

Restraints in the Global Nucleotide Market

Despite increasing awareness, a significant portion of consumers remain uninformed about nucleotides and their beneficial impacts. The potential for market growth could be hindered by this lack of comprehension, particularly in regions where the consumption of functional foods is not widespread.

Market Trends of the Global Nucleotide Market

The increasing consumer inclination towards natural and clean-label ingredients has spurred a growing demand for nucleotides sourced from natural origins, prompting manufacturers to prioritize sustainable and organic sourcing practices in response to this trend.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Nucleotide Market by Type

  • Market Overview
  • Food Grade
  • Lab Grade
  • and Industry Grade

Global Nucleotide Market by Application

  • Market Overview
  • Pharmaceuticals
  • Food & beverage additive
  • Animal feed additive
  • and Others

Global Nucleotide Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Thermo Fisher Scientific (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • New England BioLabs (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takara Bio (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lonza Group (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Promega Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QIAGEN (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Creative BioMart (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bioss (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GenScript (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioVision (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Enzo Biochem (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SERVA Electrophoresis (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IDT (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Life Technologies (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sigma-Aldrich (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments